Access anti-HBc Total
FDA 510(k) K253687 · Beckman Coulter, Inc.
Submission
- Device name
- Access anti-HBc Total
- Applicant
- Beckman Coulter, Inc.
Chaska, MN, US - Received
- November 21, 2025
- Decision date
- February 19, 2026
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- SEI – Qualitative And Quantitative Hepatitis B Virus Antibody Assays
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3173
- Specialty
- Microbiology
In vitro diagnostic devices intended for use in the detection of antibodies to HBV. These devices are intended to aid in the diagnosis of HBV infection in persons with signs and symptoms of hepatitis and in persons at risk for HBV infection. Anti-HBs assay results may be used as an aid in the determination of susceptibility to HBV infection in individuals prior to or following HBV vaccination or…
Other 510(k)s with product code SEI
More from Beckman Coulter, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K252169 | Access BNP IINBC · Traditional | 03/24/2026SE |
| K254059 | Access anti-HBc IgMSEI · Traditional | 03/13/2026SE |
| K251995 | Access anti-HAV IgMLOL · Traditional | 01/27/2026SE |
| K250588 | Access Rubella IgGLFX · Traditional | 11/17/2025SE |
| K252580 | iQ200 SeriesLKM · Special | 09/10/2025SE |
| K243846 | Access anti-HAVLOL · Traditional | 09/09/2025SE |
| K243804 | MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional | 08/20/2025SE |
| K250036 | MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional | 08/15/2025SE |
| K243483 | Access hsTnIMMI · Traditional | 08/01/2025SE |
| K250084 | MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)LTT · Traditional | 07/18/2025SE |
Questions and answers
When was Access anti-HBc Total cleared by the FDA?
Access anti-HBc Total (K253687) received a 510(k) decision of Substantially Equivalent on February 19, 2026, 90 days after the submission was received.
What is the product code of K253687?
The FDA product code is SEI – Qualitative And Quantitative Hepatitis B Virus Antibody Assays, a Class II (moderate risk) device regulated under 21 CFR 866.3173.